GB9808896D0 - Novel compound - Google Patents
Novel compoundInfo
- Publication number
- GB9808896D0 GB9808896D0 GBGB9808896.6A GB9808896A GB9808896D0 GB 9808896 D0 GB9808896 D0 GB 9808896D0 GB 9808896 A GB9808896 A GB 9808896A GB 9808896 D0 GB9808896 D0 GB 9808896D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compound
- novel
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
| JP2000545858A JP2002513019A (ja) | 1998-04-25 | 1999-04-23 | パロキセチン・アスコルビン酸塩 |
| IDW20002169A ID26654A (id) | 1998-04-25 | 1999-04-23 | Paroksetin askorbat |
| IL13908199A IL139081A0 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
| IDW20002168A ID26083A (id) | 1998-04-25 | 1999-04-23 | Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns |
| EA200001104A EA200001104A1 (ru) | 1998-04-25 | 1999-04-23 | Аскорбат пароксетина |
| SK1591-2000A SK15912000A3 (sk) | 1998-04-25 | 1999-04-23 | Askorbát paroxetínu, spôsob jeho výroby a jeho použitie |
| APAP/P/2000/001963A AP2000001963A0 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate. |
| TR2000/03084T TR200003084T2 (tr) | 1998-04-25 | 1999-04-23 | Paroxetine askorbat |
| EP99918151A EP1089995A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
| HU0102116A HUP0102116A3 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate, process for its preparation and its pharmaceutical use |
| BR9909868-7A BR9909868A (pt) | 1998-04-25 | 1999-04-23 | Ascorbato de paroxetina |
| AU36184/99A AU3618499A (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
| KR1020007011809A KR20010042977A (ko) | 1998-04-25 | 1999-04-23 | 파록세틴 아스코르베이트 |
| CA002330055A CA2330055A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
| PL99343677A PL343677A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
| CN99805160A CN1297448A (zh) | 1998-04-25 | 1999-04-23 | 帕罗西汀抗坏血酸盐 |
| PCT/GB1999/001244 WO1999055698A1 (en) | 1998-04-25 | 1999-04-23 | Paroxetine ascorbate |
| ZA200005912A ZA200005912B (en) | 1998-04-25 | 2000-10-23 | Paroxetine ascorbate. |
| NO20005352A NO20005352D0 (no) | 1998-04-25 | 2000-10-24 | Paroksetinaskorbat |
| BG104940A BG104940A (bg) | 1998-04-25 | 2000-11-13 | Пароксетин аскорбат |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9808896D0 true GB9808896D0 (en) | 1998-06-24 |
Family
ID=10831008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9808896.6A Ceased GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (sk) |
| JP (1) | JP2002513019A (sk) |
| KR (1) | KR20010042977A (sk) |
| CN (1) | CN1297448A (sk) |
| AP (1) | AP2000001963A0 (sk) |
| AU (1) | AU3618499A (sk) |
| BG (1) | BG104940A (sk) |
| BR (1) | BR9909868A (sk) |
| CA (1) | CA2330055A1 (sk) |
| EA (1) | EA200001104A1 (sk) |
| GB (1) | GB9808896D0 (sk) |
| HU (1) | HUP0102116A3 (sk) |
| ID (2) | ID26654A (sk) |
| IL (1) | IL139081A0 (sk) |
| NO (1) | NO20005352D0 (sk) |
| PL (1) | PL343677A1 (sk) |
| SK (1) | SK15912000A3 (sk) |
| TR (1) | TR200003084T2 (sk) |
| WO (1) | WO1999055698A1 (sk) |
| ZA (1) | ZA200005912B (sk) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| CA2471144C (en) | 2002-01-09 | 2011-06-07 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| CN110607553B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备粒径可调的药物或药物中间体单晶或无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| ES2058061T3 (es) * | 1985-10-25 | 1994-11-01 | Beecham Group Plc | Derivado de piperidina, su preparacion y su uso como medicamento. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Application Discontinuation
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352D0/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999055698A1 (en) | 1999-11-04 |
| HUP0102116A3 (en) | 2002-12-28 |
| PL343677A1 (en) | 2001-08-27 |
| SK15912000A3 (sk) | 2001-04-09 |
| JP2002513019A (ja) | 2002-05-08 |
| EA200001104A1 (ru) | 2001-04-23 |
| EP1089995A1 (en) | 2001-04-11 |
| IL139081A0 (en) | 2001-11-25 |
| ID26083A (id) | 2000-11-23 |
| HUP0102116A2 (hu) | 2002-05-29 |
| ZA200005912B (en) | 2001-12-19 |
| TR200003084T2 (tr) | 2001-02-21 |
| CN1297448A (zh) | 2001-05-30 |
| NO20005352L (no) | 2000-10-24 |
| BG104940A (bg) | 2001-09-28 |
| AU3618499A (en) | 1999-11-16 |
| NO20005352D0 (no) | 2000-10-24 |
| BR9909868A (pt) | 2000-12-19 |
| KR20010042977A (ko) | 2001-05-25 |
| AP2000001963A0 (en) | 2000-12-31 |
| CA2330055A1 (en) | 1999-11-04 |
| ID26654A (id) | 2001-01-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9801392D0 (en) | Novel compounds | |
| GB0119695D0 (en) | Novel compound | |
| GB9805348D0 (en) | Compound | |
| GB9827431D0 (en) | Novel compound | |
| GB9808268D0 (en) | Compound | |
| GB9808896D0 (en) | Novel compound | |
| GB9808894D0 (en) | Novel compound | |
| GB9823175D0 (en) | Compound | |
| GB9815871D0 (en) | Novel compound | |
| GB9821732D0 (en) | Novel compound | |
| GB9826172D0 (en) | Novel compound | |
| GB9817337D0 (en) | Novel compound | |
| GB9817323D0 (en) | Novel compound | |
| GB9817321D0 (en) | Novel compound | |
| GB9817310D0 (en) | Novel compound | |
| GB9817307D0 (en) | Novel compound | |
| GB9823856D0 (en) | Novel compound | |
| GB9817338D0 (en) | Novel compound | |
| GB9820404D0 (en) | Novel compound | |
| GB9827277D0 (en) | Novel compound | |
| GB9802640D0 (en) | Novel compounds | |
| GB9827830D0 (en) | Novel compounds | |
| GB9800337D0 (en) | Novel compounds | |
| GB9800324D0 (en) | Novel compounds | |
| GB9800317D0 (en) | Novel compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |